Shalini Sharp
2014 - Ultragenyx Pharmaceutical
In 2014, Shalini Sharp earned a total compensation of $512.1K as Chief Financial Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 18% decrease compared to previous year.
Compensation breakdown
Bonus | $30,000 |
---|---|
Non-Equity Incentive Plan | $117,563 |
Salary | $350,000 |
Other | $14,500 |
Total | $512,063 |
Sharp received $350K in salary, accounting for 68% of the total pay in 2014.
Sharp also received $30K in bonus, $117.6K in non-equity incentive plan and $14.5K in other compensation.
Rankings
In 2014, Shalini Sharp's compensation ranked 10,190th out of 13,032 executives tracked by ExecPay. In other words, Sharp earned more than 21.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,190 | 22nd |
Manufacturing | 3,869 | 22nd |
Chemicals And Allied Products | 1,328 | 21st |
Drugs | 1,061 | 23rd |
Pharmaceutical Preparations | 814 | 22nd |
Sharp's colleagues
We found three more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2014.